Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4Lymphoid 3Sarcoma 1Dermatologic 1

Conditions

Melanoma 33Carcinoma, Non-Small-Cell Lung 6Uveal Melanoma 5Skin Neoplasms 5Neoplasms 5Lymphoma, T-Cell, Cutaneous 4Kidney Neoplasms 4Sarcoma 3Prostatic Neoplasms 3Mycosis Fungoides 3Esophageal Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Sezary Syndrome 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Lung Neoplasms 2Endometrial Neoplasms 2Carcinoma, Basal Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urticaria Pigmentosa 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Small Cell Lung Carcinoma 1Pruritus 1Pancreatic Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 17Cyclophosphamide 17Antilymphocyte Serum 17fludarabine phosphate 16Busulfan 15Tacrolimus 14Mycophenolic Acid 10Methotrexate 10Cyclosporine 10Methylprednisolone 9Whole-Body Irradiation 7Melphalan 7Filgrastim 7Sirolimus 6Psychiatric Rehabilitation 6Etoposide 6Radiotherapy 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4sargramostim 3Polymerase Chain Reaction 3Everolimus 3Epoetin Alfa 3Early Intervention, Educational 3Darbepoetin alfa 3Thiotepa 2Therapeutics 2Prednisone 2Ondansetron 2Moxifloxacin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Blood Specimen Collection × Dermatologic × Clear all
NCT01916135 2020-04-27

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
11 enrolled
DermatologicLymphoidPlasma cellSarcoma

Carcinoma, Lymphoma, Melanoma, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡